IRWD icon

Ironwood Pharmaceuticals

227 hedge funds and large institutions have $1.12B invested in Ironwood Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 80 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

26% less capital invested

Capital invested by funds: $1.5B → $1.12B (-$383M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

59% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 51

Holders
227
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$73.6M
Puts
$186K
Net Calls
Net Calls Change

Top Buyers

1 +$15.6M
2 +$14.2M
3 +$13.3M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
+$11.1M
5
Renaissance Technologies
Renaissance Technologies
New York
+$9.6M

Top Sellers

1 -$30.5M
2 -$9.02M
3 -$8.35M
4
UBS Group
UBS Group
Switzerland
-$7.75M
5
SSA
Schonfeld Strategic Advisors
New York
-$6.29M
Name Holding Trade Value Shares
Change
Change in
Stake
201
$6.8K
202
$5.74K
203
$4.09K
204
$3.85K
205
$2.95K
206
$2K
207
$1.76K
208
$1.41K
209
$1.39K
210
$1.23K
211
$1.11K
212
$1.04K
213
$939
214
$659
215
$652
216
$632
217
$554
218
$522
219
$469
220
$228
221
$222
222
$158
223
$98
224
$66
225
$33